WASHINGTON, June 13 -- Airlines for America has submitted comments to the U.S. Environmental Protection Agency regarding its proposed 2026 Multi-Sector General Permit for stormwater discharges. The organization contends that several requirements in the draft permit are impractical and inconsistent with the unique operational realities of aviation. The airline industry, a vital pillar of the national economy, transports millions of passengers and thousands of tons of cargo daily. Airlines for Am more ST

WASHINGTON, June 14 -- Baxter International Inc., Deerfield, Illinois has submitted comments to the U.S. Department of Commerce expressing concerns regarding the ongoing Section 232 national security investigation into imports of pharmaceuticals and pharmaceutical ingredients. The global medical products company emphasized the role of international supply chains in ensuring consistent availability of essential hospital pharmaceutical products. In their May 6, 2025, submission, Vanessa M. Brill, more ST

WASHINGTON, June 14 -- The Biotechnology Innovation Organization has strongly cautioned the Bureau of Industry and Security against imposing tariffs on imported pharmaceuticals and pharmaceutical ingredients. The trade association argues that such measures would not only fail to strengthen U.S. biomanufacturing but would actively undermine national security and economic leadership in the biotechnology sector. This stance comes in response to a Section 232 national security investigation initiate more ST

WASHINGTON, June 13 -- The Canadian Chamber of Commerce has voiced strong opposition to potential U.S. tariffs or import restrictions on pharmaceutical products. In a letter to Eric Longnecker, Deputy Assistant Secretary for Technology Security at the U.S. Department of Commerce Bureau of Industry and Security, the Chamber warned that such measures would undermine U.S. medical supply chain security. Representing over 200,000 Canadian businesses, the Chamber stated that across-the-board tariffs  more ST

WASHINGTON, June 14 -- A prominent health policy expert has voiced strong opposition to proposed tariffs on pharmaceutical products and ingredients imported from allied nations. The warning, submitted to the U.S. Department of Commerce Bureau of Industry and Security, emphasizes the severe impact such tariffs could have on millions of Americans managing chronic diseases. Kenneth E. Thorpe, Robert W. Woodruff professor at Emory University's Rollins School of Public Health and honorary chair of t more ST

WASHINGTON, June 14 -- The European Union has strongly cautioned the U.S. Department of Commerce Bureau of Industry and Security Office of Strategic Industries and Economic Security against imposing tariffs on imported pharmaceuticals and pharmaceutical ingredients. In comments submitted on May 6, 2025, in response to a Section 232 national security investigation, the Delegation of the European Union to the United States of America expressed concern that such measures appear driven by industrial more ST

WASHINGTON, June 13 -- The Union League Club of Chicago and League of Women Voters of Chicago have expressed strong opposition to a proposed rule from the Office of Personnel Management. The rule, titled "Improving Performance, Accountability and Responsiveness in Civil Service," was published in the Federal Register on April 23, 2025. "This is not reform; it will be a rupture," asserted the organizations in their correspondence to the federal agency. The groups contend the regulation would re more ST

WASHINGTON, June 14 -- The API Innovation Center, a non-profit public benefit entity, has submitted a strong statement to the U.S. Department of Commerce Bureau of Industry and Security highlighting critical vulnerabilities in the U.S. pharmaceutical supply chain. The organization contends that foreign government subsidies, unfair trade practices, and outdated domestic policies are undermining the American generic pharmaceutical sector, jeopardizing national health security. APIIC's core missio more ST

WASHINGTON, June 13 -- Novo Nordisk has submitted comments to the U.S. Department of Commerce regarding its Section 232 national security investigation into pharmaceutical imports (Docket No. 250414-0065). While committed to its significant U.S. manufacturing investments, the global healthcare company urged against broad tariffs on products from allied nations, arguing they would disrupt supply chains, inflate prices, and jeopardize future investments. Instead, Novo Nordisk highlighted a more pr more ST

WASHINGTON, June 13 -- The Small Business and Entrepreneurship Council has opposed proposals to impose Section 232 tariffs on pharmaceutical imports from Europe and Japan. In a letter addressed to Eric Longnecker and Stephen Astle of the U.S. Department of Commerce, SBE Council President and CEO Karen Kerrigan argued that such tariffs would have severe "harmful and unintended consequences" for health consumers and small U.S.-based pharmaceutical companies. The SBE Council, an advocate for entre more ST

WASHINGTON, June 14 -- The Snoqualmie Indian Tribe is urging the U.S. Department of the Interior Fish and Wildlife Service to reconsider a proposed rule that would rescind the definition of "Harm" under the Endangered Species Act. In a letter sent to the wildlife agency, Matthew Baerwalde, senior environmental policy analyst for the tribe, articulated concerns that the move directly threatens tribal treaty rights and species conservation efforts. Baerwalde emphasized the tribe's historical cont more ST

WASHINGTON, June 13 -- Public Knowledge asserts to the Federal Trade Commission that content moderation by social media platforms does not equate to censorship. The document, submitted in response to the commission's inquiry into technology platform censorship, argues that moderation decisions reflect legitimate business choices protected by the First Amendment, not ideological bias. The group urges the agency to focus on promoting competition rather than regulating content policies. Empirical  more ST